drugset / Trial / NCT01739530
Safety of Repaircell in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Allogenic differentiated adipocytes (ANT-adip-AL) is produced by well-established techniques including cell harvesting from lipoaspirates obtained from healthy donors, expansion of adipose tissue derived stem cells, and differentiation into pure and immature adipocytes. This was an open-label study. Subjects were received subcutaneous injection of ANT-adip-AL and followed for 8 weeks according to the clinical trial protocol.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-11
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Repaircell | Cell therapy | — | Subcutaneous |
Indications
No indication recorded.